Computational modelling is becoming ever more important for obtaining regulatory 3 approval for new medical devices. An accepted approach is to infer performance in 4 a population from an analysis conducted in an idealized or ‗average' patient; we 5 present here a method for predicting the performance of an orthopaedic implant 6 when released into a population -effectively simulating a clinical trial. Specifically 7
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Email.: pprender@tcd.ie Computational analysis of biomechanical implants has been performed ever since 2 finite element modelling emerged as a practical tool for analysing complex shapes . 3 In the early days the clinical utility was limited because of the lack of 4 computational power; often simple two-dimensional geometries were used 5 (Huiskes and Chao, 1983; Prendergast, 1997) . As computational power increased 6 models did improve as patient-specific geometries derived from medical images 7 could be modelled more easily. With patient-specific geometric modelling, 8 limitations of loading and material properties could be addressed; daily loading 9 datasets were developed (Bergmann et al., 2001; Heller et al., 2005) and models 10 incorporating more advanced patient-specific material properties were advanced 11 (see for example Helgason et al., 2008) . Current technologies now allow for 12 accurate modelling, corroborated against experimental or other data for many 13 types of medical device, e.g. for orthopaedic implants (Verdonschot and Huiskes, 14 1997; Taylor and Barrett, 2003; Stolk et al., 2007; Lennon et al., 2007) . While 15 these analyses give accurate predictions of how an implant will perform in a 16 representative case, they may not give good predictions of how an implant will 17 perform when released into a population because a medical device may perform 18 superbly in an average individual but will perform poorly in individuals whose 19 anatomy or pathology differ from average. The variable performance in a 20 population has been shown by, for example, the Swedish hip register where the 21 probability of a Müller hip prostheses lasting for 10 years is 81.7% ±4.1% (Malchau 22 et al., 1993) whereas for a Lubinus it is 96.3% ± 0.3% (Kärrholm et al., 2007) . 23
Awareness of the need to account for such differences in the range of performance 24 of different implants has led to a new wave of modelling approaches that attempt 25 to include aspects of population variability when simulating implant behaviour, There are several factors that may cause variation in the outcome; these 4 may be classified as either environmental factors or genetic factors. Environment 5 factors include: 6 surgical variation in implant positioning, as some implant designs may be 7 more sensitive to being inserted in non-optimal positions than others, 8 loading, as each patient will subject the device to different loads 9 The genetic differences between patients that are particularly relevant to the 13 performance of a load-bearing implant include genetic variation in tissue 14 mechanoresponsiveness. As Frost (1987) speculated, each individual's bone tissue 15 has a somewhat different response to mechanical stress -and this 16 mechanosensitivity will also vary with age; some patients' bone tissue will be 17 indifferent to the change in stress whereas other bone tissue will be 18 mechanosensitive to a considerable degree leading to different amounts of bone 19 resorption around the implant, or different patterns of bone ingrowth. Many 20 follow-up studies have shown this; recently for example Panisello et al (2009) 21 showed that an anatomic non-cemented stem had bone loss which ranged from 12%
In this paper we test the hypothesis that, if two devices are to be compared 1 an analysis based on an idealised or average patient will lead to different 2 conclusions than one that models the variability inherent in human populations. 3
To test this hypothesis a finite element model of an intramedullary implant is 4 used, with variability included in bone geometry and mechanosensitivity of the 5 bone tissue. An intramedullary implant is chosen as intramedullary fixation is 6 frequently used for many orthopaedic implants (Prendergast, 2001) ; furthermore, 7 cortical bone containing a tapered straight stem ( Fig. 1) . A force was applied to 20 the stem at nodes at the centre of its top surface while all nodes at the distal end 21 of the bone were restrained from movement. Total applied force to the stem was 22 calculated by estimating the equivalent force on the bone annulus to produce a 23 pressure that could induce an axial strain of 1,500 µε in the bone tube. This strain magnitude was chosen as representative of a maximum strain in a long bone 1 diaphysis under normal conditions (Fritton and Rubin, 2001). Debonded contact 2 was assumed between the stem and bone with a friction coefficient of 0.3. A 3 region of elements near the restraints was excluded from the bone adaptation 4 simulation due to unphysiological strains arising from the restraints in this region. 5
The bone remodelling algorithm used in this study was presented in Mulvhill 6
and Prendergast (2008) . Briefly, the algorithm follows the proposal of Frost (1983, 7 1987, 1990 ) that bone mechanoresponsiveness is categorised into four ‗windows': a 8 disuse window where strain is below a minimum effective strain, denoted here as 9 ε min , an adapted window where no net change occurs between ε min and ε max , a 10 window where modelling occurs to create new bone mass on surfaces above ε max , 11 and a pathologic region where matrix damage causes bone loss -in our 12 remodelling algorithm we denote this occurring above ω crit . (In this study ω crit = Temperature is assumed to be 37 o C.) 22
During resorptive activity osteoclasts are assumed to resorb bone causing a 23 local rate of apparent density reduction of -C g/cm 3 per day while during 24 formation osteoblast deposition is assumed to be a fraction, n, of osteoclast resorption, giving a local rate of apparent density increase of nC g/cm 3 per day; 1 the resorption rate C was calculated based on an assumption that a BMU is capable 2 of resorbing 1.4 μm/day (Eriksen et al., 1984a) and that the ratio of formation to 3 resorption is n=0.31 (Eriksen et al., 1984b). The following algorithm describes the 4 four remodelling states: 5
If ω < ωcrit then
Strain-based formation (overuse)
Remodelling equilibrium (stasis)
The algorithm for bone remodelling is illustrated in Fig. 2 . This algorithm is used 7 with a finite element analysis to simulate changes in bone density over time due to 8 stress-shielding arising from introduction of the intramedullary stem. 9
Proceeding as illustrated in Fig. 2 , the simulation is initiated by calculating 10 the strain field within the bone using a finite element analysis. Each bone element 11 is checked for remodelling status, and its rate of change of density is calculated 12 according to the algorithm above. Next the apparent density change is calculated 13 Variability was introduced into the simulations by varying bone size and 10 mechanosensitivity. First, a scaling transformation was used to warp the extra-11 cortical surface of the bone so that every case in the trial would have a different 12 diameter bone reflecting the variability that exists in the human population. A 13 uniform distribution for bone diameter was assumed in the population, and a 14 random number was generated within a range of 20 mm to 25 mm for the bone 15 diameter, taken from Noble et al (1988) . Secondly, the strain-based resorption 16 (ε min ) and formation (ε max ) thresholds were also randomly generated in order to 17 represent variable mechanosensitivity, again assuming a uniform distribution, with 18 a range of 1,000±500 µε for ε min and 2,000±500 µε for ε max . Therefore the ‗width ' 19 of the zone of equilibrium strains in the reference case is 1,000 µε, with variability 20 in the strain-based resorption (ε min ) and formation (ε max ) thresholds set, following 21
Frost (2003) as ±500 µε. Therefore the reference case representing idealized or ‗average' bone has the following variables: bone external diameter = 22.5 mm, ε min 23
In order to test the concept of a clinical trial for two intramedullary stems, initially greatest with the low stiffness stem but the damage obtained with the 13 high stiffness stem eventually exceeds it (Fig. 4a ). On the other hand, the low 14 stiffness stem always induces a higher damage at the interface (Fig. 4a ). Density Reductions in bone density cause increased migration of the implant under a 17 cyclic load. In the reference case the mechanism causes a notable difference in 18 the migration rate of the two implants, with the stiffer 200 GPa implant migrating 19 more rapidly and thus failing more rapidly, than the low stiffness 20 GPa implant 20 ( Fig. 5) . 21
However, when the simulation is run on the whole population very 22 significant variation can be seen ( Fig. 6) showing that the outcome is very variable 23 in a population. Analysis of time-to-failure data shows that there is no statistical difference in the performance of the two implants in the population, despite the 1 differences in the performance of the reference case (Table 1) . 2 3
Discussion 4
This study set out to test the hypothesis that an analysis based on a method for 5 predicting the performance in a population will lead to different conclusions than 6 an analysis based on an idealised average patient. Using an intramedullary implant 7
as an example, we found that the differences reported in an average idealised 8 case are not found in an analysis that simulates the behaviour of the implant when 9 used in a population. Deterministic analyses predicted that an intramedullary 10 implant made of low stiffness material would migrate less than a high stiffness 11
implant and should therefore have greater longevity; however our results show 12 that if the variability in a population is modelled this result no longer holds -the 13 data shows no statistical difference when variability of the kind that occurs in a 14 population was included. Therefore the factors causing a variable outcome in a 15 population are such that there is a significant overlap in the performance of two 16 designs of intramedullary-fixated implants is corroborated. 17
The limitations of this study are that the analysis pertains only to a 18 simplified intramedullary implant. A real anatomic bone shape and implant design 19 could have been used where, we might expect, the variability would be even 20 greater -in this respect it is more stringent to test the hypothesis in a simplified 21 geometry compared to a complex anatomical geometry where the variability would 22 be even greater. Similarly we could have varied other parameters such as the 23 loading whereas in these simulations the loading is proportional to bone cross-sectional area so that each bone is assumed to have an identical pre-surgical 1 homeostatic strain level of 1500 µε; again variation of loading or the homeostatic 2 strain assumption would be likely to further increase variability. A limitation of the 3 finite element analysis is that the bone properties used are isotropic and 4 homogeneous whereas it is known that bone stiffness is anisotropic and spatially 5 heterogeneous. 6
The bone remodelling algorithm used has been presented previously 7 in 3D around noncemented total hip replacements (Scannell and Prendergast, 12 2009 ). Finally in this study no consideration was given to the possible repair of the 13 interface when the resorbed tissue is replaced by soft tissue and then bone in a 14 process of osseointegration (Prendergast, 2007) . 15
The results presented here have implications for the conduct of preclinical 16 testing using finite element modelling (Stolk et al., 2007) . It suggests that 17 simulations of implants in population-averaged or -ideal‖ anatomies may lead to 18 conclusions that one implant is superior to another would not be borne out in a 19 clinical trial. Since computational power is now sufficient to do simulations of 20 clinical trials of the kind presented here then there is a case that these should be 21 included in pre-clinical testing platforms used in seeking regulatory approval for 22 devices. Such pre-clinical analyses could be aided by making available reference 23 libraries of models of skeletal and other relevant anatomical structures, perhaps 24 even different libraries for different ethnic groups reflecting differences in anatomy. Results of this study also suggest the importance of mechanoregulation 1 parameters, which will also be variable in the population due to genetic 2 differences and age variability in patients (Frost, 1987; Khayyeri et al., 2011). 3 In this study we have simulated a clinical trial on a simplified intramedullary 4 implant. We have shown that, despite discernable differences in implants when 5 analyses are performed on standard cases, there is no statistically significant 6 difference when the implants are subjected to a simulated clinical trial. 7
A further aspect to be considered is that it is not the average performance 8 that is important, but rather the proclivity to perform below par in a percentage 9 of cases. Computational simulations of clinical trials have the potential to analyse 10 this aspect of the behaviour of an implant design 11
In conclusion this study has identified that it is possible to perform a 12 simulation of a clinical trial, and that such simulations have a value over and above 13 analyses performed in idealised population-averaged reference cases since 14 simulated clinical trials lead to different conclusions. It is proposed that these 15 kinds of simulations be carried out taking account of the differences in the 16 response of tissues to mechanical stress, as well as variations in anatomy. 17
Furthermore an advantage of this kind of work is that the results are, in principle, 18 validatable against the results of the clinical trial. If this proved to be true then it 19 would overcome one of the most often made criticisms of computer modelling in 20 implant analysis: the lack of falsifiability of the models.
The research reported in this paper has been funded by a Principal Investigator 1 grant to P. J. Prendergast funded by Science Foundation Ireland. Figure 1 : A 3D finite element mesh of an intramedullary implant of the reference 2 dimension of 22.5 mm external bone diameter. Note that the loading applied to 3 the implant is that which would give a 1,500 με in the longitudinal direction were 4
it applied directly to the bone surface. 5 is used to compute the stress and strain in the bone tissue. If damage (denoted ω) 7
is above a critical value then the tissue is pathologically injured and it resorbs, 8
otherwise strain-adaptive remodelling occurs as follows: if strain (denoted ε) is 9
above a threshold then addition of bone tissue occurs otherwise if it is below a 10 threshold then resorption occurs, otherwise it is in homeostasis and neither 11 resorption or deposition occurs. When the changes computed are very low the 12 structure is converged and the algorithm ‗exits'. 13 density changes in the bone tissue. Note that GZ stands for Gruen Zone, i.e. a 19
region of the bone surrounding the implant. 20 Figure 5 : In the reference case there is a difference in the subsidence rate of the 21 two implants, with the 20 GPa implant migrating more rapidly and this failing more 22 rapidly, than the 200 GPa implant. 23 Figure 6 : When all analyses are run (100 per implant, therefore 200 in total) very 24 significant variation is in subsidence is predicted. Statistical analysis shows that 25
there is no statistical difference between the performance of the implants (refer 26
to Table 1 ). 27 28 1   Table 1 : Analysis of time-to-failure data shows that there is no statistical 2 difference in the performance of the two implants in the population, despite the 3 apparent differences in the performance of the reference models. 4 Table 1 : Analysis of time-to-failure data shows that there is no statistical 1 difference in the performance of the two implants in the population, despite the 2 apparent differences in the performance of the reference models. 3 there is no statistical difference between the performance of the implants (refer 6
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